Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
Type:
Application
Filed:
December 19, 2014
Publication date:
April 16, 2015
Applicant:
JAVELIN PHARMACEUTICALS, INC.
Inventors:
Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 75 mg, e.g., from about 18.75 mg to about 37.5 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
Type:
Grant
Filed:
May 12, 2011
Date of Patent:
February 3, 2015
Assignee:
Javelin Pharmaceuticals, Inc.
Inventors:
Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
Abstract: The invention relates to a device for the time-controlled dispensing of pharmaceutical compositions to a patient. The device is intended to allow multiple doses of pharmaceutical compositions to be delivered to a patient over a predetermined or programmable dosing schedule.
Abstract: The invention relates to a device for the time-controlled dispensing of pharmaceutical compositions to a patient. The device is intended to allow multiple doses of pharmaceutical compositions to be delivered to a patient over a predetermined or programmable dosing schedule.